Dr. Ben Raphael – “Quantifying Tumor Heterogeneity Across Space and Time”
Dr. Ben Raphael (https://twitter.com/benjraphael) presents “Quantifying Tumor Heterogeneity Across Space and Time” as part of the #mathonco (https://twitter….
Dr. Ben Raphael (https://twitter.com/benjraphael) presents “Quantifying Tumor Heterogeneity Across Space and Time” as part of the #mathonco (https://twitter….
PURPOSE Multiple studies have demonstrated that electronic patient-reported outcomes (ePROs) improve overall survival and quality of life in cancer care. However, there are no specific…
Marwan Fakih (Duarte, United States of America) We have previously reported significant differences between the tumor immune microenvironm ent (TIME) of primary colorectal cancer (CRC-P)…
This cohort study evaluates tumor mutational burden and outcomes in patients with diverse advanced cancers treated with immunotherapy.
May is Mental Health Awareness Month! Join us on @DailyBlastLIVE as we dive into important conversations about mental wellness. Can talking about it too much…
This cross-sectional study examines the prevalence of germline findings in patients undergoing tumor/normal matched sequencing among cancer types lacking guidelines.
3017 Background: Next generation sequencing (NGS) of tumor tissue and plasma (circulating tumor DNA [ctDNA]) are used clinically to identify actionable genomic alterations, with implications…
3077 Background: While targeted DNA-seq can detect clinically actionable fusions in tumor tissue samples, technical and analytical challenges may give rise to false negatives. RNA-based,…
SignUpGenius is an online sign up software to simplify volunteer management and event planning. Customize online sign up sheets and schedules for schools, nonprofits, business…
Nature Biotechnology – Tumor-reactive T cell receptors are predicted based on single-cell RNA sequencing and single-cell T cell receptor sequencing.
Some of the final work of a late University of Virginia School of Medicine scientist has opened the door for life-saving new treatments for solid…